Our study aimed to evaluate severity of pain and quality of life in terms of physical, social and emotional functions among the osteoporotic women without vertebral fractures. A total of 40 postmenopausal osteoporotic women without vertebral fractures and 40 age-matched controls were included in the study. Dual-energy x-ray absorptiometry (DEXA) values at lumbar spine (L2-4) and femoral neck, performed in our hospital in the last 6 months (retrospective data) were recorded. Quality of life was assessed with Nottingham Health Profile (NHP) and Assessment of Health-Related Quality of Life in Osteoporosis (ECOS-16). Severity of pain was measured with Visual Analog Scale (VAS). ECOS-16, VAS scores and pain, physical mobility, energy and sleep subscores of NHP were found as higher in the patient group than in the controls (p<0.05). Bone mineral density (BMD) lumbar spine and femoral neck values were found to be negatively correlated with VAS, ECOS-16, and energy, pain, physical mobility, and sleep subgroups of NHP (p<0.05). Pain and deterioration in quality of life in the osteoporotic women should be taken into consideration regardless of presence of vertebral fractures. A better understanding of pain mechanisms in postmenopausal osteoporosis will help us find more effective treatment strategies.
Introduction
Osteoporosis is systemic skeletal disorder which is characterized by an increase in bone fragility resulting from low bone mass and deterioration of bone microarchitecture (1) . It has two types. Primary type 1 osteoporosis or 'postmenopausal osteoporosis' occurs in women after menopause. Primary type 2 osteoporosis or in other words 'senile osteoporosis' is seen in both females and males after age 75 (2) . Osteoporosis has a negative impact on the health related quality of life (HRQoL) owing to the fact that it is one of major causes of mortality and morbidity (3, 4) .World Health Organization defines healthrelated quality of life as individuals' perceptions of their conditions in life, with regard to their objectives, expectations, norms and concerns, within the context of their own cultural and value systems (5) . Measurement of HRQoL holds the key to determine treatment strategies and efficacy of the treatment (6) . Various scales have been developed to evaluate osteoporosis-related HRQoL. One of them is Assessment of Health Related Quality of Life in Osteoporosis (ECOS-16) (7) . It has been proven to have good psychometric properties, so that it can be used in routine clinical practice and studies as a useful osteoporosis-related HRQoL scale (8 Comparison of health-related quality of life and severity of pain among the groups ECOS-16 and VAS-pain scores were found to be significantly higher in the patient group than in the controls (p<0.001). Patients with postmenopausal osteoporosis scored significantly higher in pain, physical mobility, energy and sleep subgroups of NHP when compared with controls (p<0.05). Significant statistical differences were not recorded in social isolation and emotional reactions subgroups of NHP among the patient groups with and without postmenopausal osteoporosis (p>0.05) ( Table 2 ). (16) found HRQoL scores of their patients with osteoporosis as lower than those of osteopenic subjects. Paker et al. (17) suggested that vertebral fractures might have a negative impact on the quality of life. Differently from these studies, our group of patients had no vertebral fracture.
The present study investigated the HRQoL in postmenopausal women without vertebral fractures. We evaluated HRQoL by using both general and disease-specific scales. In our study, osteoporotic women scored significantly higher in ECOS-16 and pain, physical mobility, energy and sleep subgroups of NHP when compared with controls. Presence of osteoporosis was not found to be associated with mental domains of HRQoL including social isolation and emotional reactions. This finding was previously reported in the study of Adiguzel et al. (18) where the patients with postmenopausal osteoporosis had poorer NHP scores except emotional reaction scores. Altindag et al. (19) reported poorer HRQoL scores in postmenopausal women with osteoporosis than healthy controls. Similarly, they used ECOS-16 for evaluating HRQoL. Also Pamuk et al. (6) and Yılmaz et al. (20) suggested that osteoporosis negatively impaired quality of life scores which were assessed with QUALEFFO.
We found higher VAS-pain scores in the patients than in controls. This was previously found in the study of Altindag et al. (19) Theoretically, osteoporosis without vertebral fractures is silence, it does not cause pain. However, there is some evidence that osteoporosis leads to pain. It can be due to concomitant osteoarthritis, musculoskeletal malfunction or muscular atrophy (21) . Also in the previous studies, it was reported that pain was relieved after osteoporosis therapy (22, 23) . Larger studies are necessary to understand the pain mechanisms in postmenopausal osteoporosis. There were some limitations in our study. The first one was relatively small number of subjects. The second one was lack of evaluation of the patients in terms of concomitant diseases such as osteoarthritis and fibromyalgia whic may contribute to pain. Our study demonstrated that women with postmenopausal osteoporosis without vertebral fractures had poorer quality of life than healthy women in terms of severity of pain, sleep and physical functions. Thus physicians should take into consideration pain and HRQoL of the osteoporotic women despite the fact that they had no vertebral fracture. A better understanding of pain mechanisms in postmenopausal osteoporosis will provide us a comprehensive approach to the pain therapy.
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